Increase in newly diagnosed type 1 diabetes and serological evidence of recent SARS-CoV-2 infection: Is there a connection?

Marco Denina(University of Turin), Luisa De Sanctis, Sergio Rosati(University of Turin), Silvia Garazzino(Ospedale Regina Margherita), Michela Trada(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Chiara Novara(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Claudia Bondone(Ospedale Regina Margherita), Martina Moretto(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Elisa Funiciello(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Davide Tinti(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Frontiers in Medicine
July 28, 2022
10.3389/fmed.2022.927099
Cited by 13

Related Papers

Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology
|Thyroid|2020|455
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
|Nature Reviews Endocrinology|2018|346
A multiplex PCR assay for the identification of animal species in feedstuffs
|Molecular and Cellular Probes|2003|235
SARS-CoV-2–Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children
|PEDIATRICS|2020|233
Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?
|Diabetes Care|2020|222